AXSM is back on traders' screens this week, after the FDA accepted Axsome Therapeutics' filing for a new narcolepsy drug in mid-July 2026. The chart that's worth studying, though, is…
AMC is back on the retail trackers this month, and it's worth pulling up the chart from the last time it ran rather than the headlines around it. In February…
RIOT's back on traders' screens this week, ranked number 20 on the Stocktwits most-active list on 13 July 2026, and that's reason enough to pull up the chart that made…
QS is back near the top of the StockTwits trending list this week, and the chart worth pulling up is one from late 2020, when the same ticker resolved a…
Reading volume reveals whether real participation backs a price move. How to interpret volume for breakouts, trends, and reversals before any indicator fires.